Ledgewood Wealth Advisors’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Hold
32,970
0.62% 27
2026
Q1
$913K Hold
32,970
0.51% 30
2025
Q4
$715K Hold
32,970
0.41% 34
2025
Q3
$499K Hold
32,970
0.3% 45
2025
Q2
$372K Hold
32,970
0.23% 52
2025
Q1
$333K Hold
32,970
0.21% 53
2024
Q4
$390K Hold
32,970
0.25% 50
2024
Q3
$380K Hold
32,970
0.26% 51
2024
Q2
$348K Hold
32,970
0.3% 41
2024
Q1
$348K Hold
32,970
0.32% 45
2023
Q4
$370K Buy
+32,970
New +$321K 0.34% 42

Other funds holding ROIV

Ledgewood Wealth Advisors's ROIV Position: Q2 2026 in Review

Ledgewood Wealth Advisors held its Roivant Sciences (ROIV) position steady in Q2 2026 at 32,970 shares worth $1.17M. The position accounts for 0.62% of the portfolio, ranked #27.

Ledgewood Wealth Advisors first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Ledgewood Wealth Advisors held 32,970 shares of Roivant Sciences worth $1.17M as of Q2 2026.
  • Ledgewood Wealth Advisors left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.62% of Ledgewood Wealth Advisors's portfolio in Q2 2026, its #27 holding.
  • Ledgewood Wealth Advisors first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Ledgewood Wealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.